News

ascopubs.org2d
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation–Positive Non–Small ...
This phase II study demonstrated the efficacy of osimertinib 80 ... ongoing with treatment. Fig 1. Flow diagram of study population. EFR, evaluable for response; FAS, full analysis set; LM, ...
ascopubs.org5d
A phase Ib/IIa trial to evaluate the safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced NSCLC.
Characterization of HER2 alterations in lung adenocarcinoma.
C&EN5d
Synthesis and Defect Characterization of Phase-Pure Zr-MOFs Based on Meso-tetracarboxyphenylporphyrin
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...